Skip to main content
. Author manuscript; available in PMC: 2023 Jan 20.
Published in final edited form as: JACC Cardiovasc Interv. 2021 Mar 17;14(7):739–750. doi: 10.1016/j.jcin.2021.01.024

Central Illustration.

Central Illustration.

A Proposed Algorithm Utilizing CYP2C19 Pharmacogenetic Testing to Individualize Oral P2Y12 Inhibitor Therapy in Patients with Coronary Artery Disease (CAD) based on the Meta-Analysis Results. ACS, Acute Coronary Syndromes; PCI, Percutaneous Coronary Intervention; RCT, Randomized Controlled Trial; LOF, Loss-of-Function; RR, Relative Risk.